Clinical Trials List
Protocol NumberDS1103-074
Not yet recruiting
2023-05-30 - 2030-05-15
Phase I
Recruiting3
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 梁逸歆 無
- Wei-Wu Chen 無
- YEN-SHEN LU 無
- 徐偉勛 無
- 陳怡君 無
- Kun-Huei Yeh 無
- 張端瑩 無
- 林季宏 無
- 吳宗哲_ 無
- 陳國興 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen 無
- Chun-Hui Lee 無
- Kuo-Ting Lee 無
- 黃怡菁 無
- 黃怡璇 無
- Jui-Hung Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chung Chao 無
- Yi-Ping Hung 無
- 黃宣恩 無
- Jiun-I Lai 無
- 唐振育 無
- 姜乃榕 無
- Chun-Yu Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
108 participants
